Carlsmed (CARL) Market Capitalization (2025 - 2026)
Carlsmed's (CARL) quarterly Market Capitalization came in at $282.6 million in Q2 2026, up 14.88% quarter-over-quarter from $246.0 million in Q1 2026.
Powered by 
Analysis
Carlsmed (CARL) Market Capitalization (2025 - 2026) Analysis & Trends
Carlsmed (CARL) has reported Market Capitalization for 2 consecutive years, with $282.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Market Capitalization changed N/A year-over-year to $282.6 million; the trailing twelve-month figure through Jun 2026 stood at $282.6 million (changed N/A YoY), and the FY2025 full-year result was $175.6 million, changed N/A from the prior year.
- Market Capitalization climbed to $282.6 million in Q2 2026 per CARL's latest filing, from $246.0 million in the prior quarter.
- Across five years, Market Capitalization topped out at $282.6 million in Q2 2026 and bottomed at $175.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Carlsmed | 424.72 Mn | 311.42 Mn | 14.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 282.60 Mn |
| Mar 31, 2026 | 245.99 Mn |
| Dec 31, 2025 | 175.64 Mn |
| Sep 30, 2025 | 282.28 Mn |